Cart
sales@molnova.com
Zelminemab
CAS No. 2225850-33-7
Zelminemab( —— )
Catalog No. M36779 CAS No. 2225850-33-7
Zelminemab (AMG-301) is a human monoclonal antibody designed to target and inhibit the PACAP type I (PAC1) receptor .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameZelminemab
-
NoteResearch use only, not for human use.
-
Brief DescriptionZelminemab (AMG-301) is a human monoclonal antibody designed to target and inhibit the PACAP type I (PAC1) receptor .
-
DescriptionZelminemab (AMG-301) is a human monoclonal antibody that inhibits PACAP type I (PAC1) receptor.
-
In Vitro——
-
In VivoAnimal Model:Sprague-Dawley rats, electricalstimulation was performed on the intact dura mater abovethe middle meningeal artery.Dosage:10 mg/kg Administration:i.v.; once Result:Induced an inhibition of stimulus-evoked nociceptive activity in the trigeminocervical com-plex (TCC).
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2225850-33-7
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Eloisa Rubio-Beltrán, et al. PACAP38 and PAC1 receptor blockade: a new target for headache? J Headache Pain. 2018 Aug 7;19(1):64. ?
molnova catalog
related products
-
Ilmetropium iodide
Ilmetropium iodide is a bronchodilator.
-
BMS-986235
BMS-986235 is a selective and orally active agonist of formyl peptide receptor 2 (FPR2) with EC50s of 0.41 nM and 3.4 nM for hFPR2 and mFPR2, respectively.
-
(S,R,S)-AHPC TFA
(S,R,S)-AHPC TFA (VH032-NH2 TFA) is the VH032-based VHL ligand used in the recruitment of the von Hippel-Lindau (VHL) protein.
